Intellia Therapeutics Stock Price History
| NTLA Stock | USD 9.00 0.30 3.45% |
Below is the normalized historical share price chart for Intellia Therapeutics extending back to May 06, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Intellia Therapeutics stands at 9.00, as last reported on the 21st of March, with the highest price reaching 9.07 and the lowest price hitting 8.50 during the day.
If you're considering investing in Intellia Stock, it is important to understand the factors that can impact its price. Intellia Therapeutics holds Efficiency (Sharpe) Ratio of -0.0673, which attests that the entity had a -0.0673 % return per unit of risk over the last 3 months. Intellia Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Intellia Therapeutics' Standard Deviation of 4.79, market risk adjusted performance of 1.02, and Risk Adjusted Performance of (0.09) to validate the risk estimate we provide.
At present, Intellia Therapeutics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 161.9 M, whereas Total Stockholder Equity is forecasted to decline to about 585.8 M. . At present, Intellia Therapeutics' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 2.58, whereas Price To Sales Ratio is forecasted to decline to 18.92. Intellia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of May 2016 | 200 Day MA 17.3845 | 50 Day MA 10.1989 | Beta 1.969 |
Intellia |
Sharpe Ratio = -0.0673
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NTLA |
Estimated Market Risk
| 4.87 actual daily | 43 57% of assets are more volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Intellia Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intellia Therapeutics by adding Intellia Therapeutics to a well-diversified portfolio.
Price Book 1.0329 | Enterprise Value Ebitda (5.51) | Price Sales 15.5605 | Shares Float 97.9 M | Wall Street Target Price 43.9231 |
Intellia Therapeutics Stock Price History Chart
There are several ways to analyze Intellia Stock price data. The simplest method is using a basic Intellia candlestick price chart, which shows Intellia Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 6, 2025 | 12.8 |
| Lowest Price | March 20, 2025 | 8.7 |
Intellia Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Intellia Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Intellia Stock. It can be used to describe the percentage change in the price of Intellia Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Intellia Stock.| Intellia Therapeutics Accumulation Distribution | 231,887 | |
| Intellia Therapeutics Price Daily Balance Of Power | 0.53 | |
| Intellia Therapeutics Price Action Indicator | 0.37 | |
| Intellia Therapeutics Price Rate Of Daily Change | 1.03 |
Intellia Therapeutics March 21, 2025 Stock Price Analysis
Intellia Stock Price History Data
The price series of Intellia Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 5.0 with a coefficient of variation of 12.2. The daily prices for the period are spread out with arithmetic mean of 10.8. The median price for the last 90 days is 10.51.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 8.50 | 9.07 | 8.50 | 9.00 | 3,689,857 | |
| 03/20/2025 | 9.18 | 9.29 | 8.69 | 8.70 | 3,599,254 | |
| 03/19/2025 | 9.12 | 9.39 | 8.90 | 9.30 | 2,490,716 | |
| 03/18/2025 | 9.42 | 9.47 | 8.86 | 9.19 | 3,111,432 | |
| 03/17/2025 | 9.22 | 9.89 | 8.92 | 9.58 | 3,200,591 | |
| 03/14/2025 | 9.17 | 9.60 | 8.97 | 9.14 | 2,063,918 | |
| 03/13/2025 | 9.52 | 10.18 | 9.20 | 9.22 | 2,078,374 | |
| 03/12/2025 | 9.35 | 9.66 | 9.24 | 9.62 | 1,624,372 | |
| 03/11/2025 | 9.41 | 9.79 | 8.64 | 9.30 | 2,594,803 | |
| 03/10/2025 | 10.00 | 10.10 | 9.42 | 9.46 | 3,667,796 | |
| 03/07/2025 | 9.89 | 10.68 | 9.69 | 10.35 | 3,206,964 | |
| 03/06/2025 | 9.00 | 10.00 | 8.87 | 9.90 | 4,490,301 | |
| 03/05/2025 | 9.40 | 9.49 | 8.86 | 9.37 | 2,839,443 | |
| 03/04/2025 | 9.04 | 9.53 | 8.30 | 9.10 | 5,953,200 | |
| 03/03/2025 | 10.18 | 10.37 | 9.38 | 9.45 | 2,998,674 | |
| 02/28/2025 | 10.27 | 10.34 | 9.52 | 10.09 | 4,575,320 | |
| 02/27/2025 | 11.30 | 12.00 | 10.84 | 10.86 | 3,799,976 | |
| 02/26/2025 | 10.80 | 11.10 | 10.52 | 10.80 | 2,471,756 | |
| 02/25/2025 | 11.77 | 11.86 | 10.45 | 10.71 | 3,859,351 | |
| 02/24/2025 | 12.02 | 12.19 | 11.34 | 11.51 | 3,252,696 | |
| 02/21/2025 | 12.61 | 12.63 | 11.93 | 12.17 | 4,444,802 | |
| 02/20/2025 | 12.53 | 12.84 | 12.03 | 12.25 | 4,696,142 | |
| 02/19/2025 | 11.61 | 12.80 | 11.48 | 12.28 | 5,916,896 | |
| 02/18/2025 | 10.94 | 12.05 | 10.89 | 11.53 | 6,296,892 | |
| 02/14/2025 | 9.86 | 10.93 | 9.82 | 10.70 | 4,747,374 | |
| 02/13/2025 | 9.53 | 9.72 | 9.33 | 9.64 | 2,067,266 | |
| 02/12/2025 | 9.01 | 9.58 | 8.96 | 9.51 | 2,541,330 | |
| 02/11/2025 | 9.39 | 9.48 | 9.08 | 9.21 | 2,156,509 | |
| 02/10/2025 | 9.92 | 9.97 | 9.47 | 9.58 | 2,000,408 | |
| 02/07/2025 | 10.07 | 10.43 | 9.72 | 9.79 | 2,061,362 | |
| 02/06/2025 | 10.63 | 10.73 | 10.07 | 10.13 | 2,581,322 | |
| 02/05/2025 | 9.76 | 10.63 | 9.72 | 10.51 | 2,626,289 | |
| 02/04/2025 | 9.55 | 9.79 | 9.41 | 9.62 | 2,478,460 | |
| 02/03/2025 | 9.79 | 9.90 | 9.32 | 9.54 | 3,080,615 | |
| 01/31/2025 | 10.58 | 10.65 | 10.11 | 10.32 | 2,163,175 | |
| 01/30/2025 | 10.32 | 10.73 | 10.10 | 10.51 | 2,177,331 | |
| 01/29/2025 | 9.97 | 10.42 | 9.93 | 10.12 | 2,537,623 | |
| 01/28/2025 | 10.64 | 10.67 | 9.99 | 10.01 | 3,142,830 | |
| 01/27/2025 | 10.29 | 10.77 | 10.11 | 10.55 | 2,677,593 | |
| 01/24/2025 | 11.25 | 11.46 | 10.89 | 10.99 | 2,050,409 | |
| 01/23/2025 | 11.00 | 11.36 | 10.62 | 11.29 | 3,542,496 | |
| 01/22/2025 | 9.88 | 11.11 | 9.81 | 11.01 | 4,936,414 | |
| 01/21/2025 | 9.60 | 10.09 | 9.55 | 9.94 | 2,653,363 | |
| 01/17/2025 | 9.48 | 9.69 | 9.32 | 9.50 | 3,332,068 | |
| 01/16/2025 | 9.76 | 9.91 | 9.25 | 9.42 | 3,442,172 | |
| 01/15/2025 | 10.24 | 10.31 | 9.63 | 9.71 | 3,354,357 | |
| 01/14/2025 | 10.11 | 10.39 | 9.59 | 9.74 | 3,171,252 | |
| 01/13/2025 | 10.11 | 10.19 | 9.65 | 10.05 | 4,049,205 | |
| 01/10/2025 | 11.24 | 11.43 | 9.93 | 10.20 | 7,221,060 | |
| 01/08/2025 | 12.04 | 12.25 | 11.83 | 12.02 | 1,894,840 | |
| 01/07/2025 | 12.80 | 13.34 | 12.46 | 12.47 | 2,364,590 | |
| 01/06/2025 | 12.19 | 13.07 | 12.13 | 12.80 | 3,016,382 | |
| 01/03/2025 | 12.22 | 12.53 | 11.94 | 12.13 | 2,825,961 | |
| 01/02/2025 | 11.88 | 12.27 | 11.71 | 12.22 | 2,350,993 | |
| 12/31/2024 | 11.54 | 11.82 | 11.34 | 11.66 | 3,223,865 | |
| 12/30/2024 | 11.80 | 11.85 | 11.35 | 11.41 | 2,618,196 | |
| 12/27/2024 | 11.99 | 12.30 | 11.69 | 11.97 | 2,255,081 | |
| 12/26/2024 | 11.83 | 12.23 | 11.61 | 12.12 | 1,802,215 | |
| 12/24/2024 | 12.12 | 12.21 | 11.83 | 12.05 | 859,604 | |
| 12/23/2024 | 12.25 | 12.41 | 11.91 | 12.10 | 1,790,425 | |
| 12/20/2024 | 11.94 | 12.45 | 11.85 | 12.18 | 3,685,823 |
About Intellia Therapeutics Stock history
Intellia Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intellia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intellia Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intellia Therapeutics stock prices may prove useful in developing a viable investing in Intellia Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 98.8 M | 55.8 M | |
| Net Loss | -426.8 M | -405.4 M |
Intellia Therapeutics Quarterly Net Working Capital |
|
Intellia Therapeutics Stock Technical Analysis
Intellia Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Intellia Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Intellia Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Intellia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intellia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (0.13) | |||
| Treynor Ratio | 1.01 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Intellia Stock analysis
When running Intellia Therapeutics' price analysis, check to measure Intellia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intellia Therapeutics is operating at the current time. Most of Intellia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intellia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intellia Therapeutics' price. Additionally, you may evaluate how the addition of Intellia Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |